Loading page…
Hisamitsu Pharmaceutical Co Inc 2023 Integrated Report
Company: Hisamitsu Pharmaceutical Co Inc
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 32
The report describes FY2022 progress on materiality and sustainability priorities, reports total Group CO~2~ emissions of 34,452 t, and highlights the Company's TCFD scenario analysis. It also reports 2,769 consolidated employees as of February 28, 2023.
Indicators available in this report: